Colorectal cancer is no longer a disease of the elderly. A major Swiss study spanning four decades has uncovered a striking pattern: while screening efforts have slashed cancer rates among older adults, diagnoses in people under 50 are climbing steadily, and many are catching the disease far too late.
The research, led by scientists at the University of Geneva and published in the European Journal of Cancer, analyzed nearly 100,000 colorectal cancer cases recorded between 1980 and 2021. The findings paint an urgent picture of a demographic shift that has caught the medical community's attention and raises hard questions about why younger people are increasingly developing what was once considered an illness of advanced age.
Colorectal cancer ranks as the third most commonly diagnosed cancer worldwide and the second leading cause of cancer deaths. Global cases exceeded 1.9 million in 2022, according to the World Health Organization, with nearly 900,000 deaths. In Switzerland alone, roughly 4,500 new diagnoses occur every year, making it one of the country's three most prevalent cancers.
The Swiss data reveal a dramatic contrast between age groups. Among adults aged 50 to 74, the typical screening population, incidence rates dropped sharply: down 1.7% annually in men and 2.8% in women. Yet in patients under 50, rates climbed approximately 0.5% per year, eventually reaching nearly 7 cases per 100,000 person-years. Cancers in younger adults now account for 6.1% of all colorectal cancer cases in the country.
What makes the trend even more alarming is the stage at which younger patients are diagnosed. Nearly 28% of those under 50 had metastatic disease, meaning the cancer had already spread to other organs, compared with about 20% of older patients. Many had no personal or family history of the disease.
"Cases are now emerging in people in their thirties, with no personal or family history of the disease. These patients are often diagnosed late, by which time metastases are already present," says Dr. Jeremy Meyer, a surgeon at the University of Geneva's Faculty of Medicine and the Geneva University Hospitals.
The specific locations where cancer appears in younger patients also diverge from older populations. The increase primarily involves rectal cancers in both men and women, as well as right-sided colon cancers in young women. This pattern suggests distinct biological or environmental drivers rather than a simple acceleration of the same disease seen in older cohorts.
The cause remains a mystery. Researchers suspect a constellation of factors: dietary shifts, rising obesity, sedentary lifestyles, and early-life environmental exposures that may alter the gut microbiome. Yet no single explanation fully accounts for the trend, leaving scientists searching for answers.
In response to the crisis, some countries have begun lowering screening recommendations. The United States, for instance, now recommends starting at age 45 rather than 50. For those with family history or hereditary risk, screening should begin even earlier. Dr. Meyer notes that heightened public awareness of warning signs could catch more cancers before they advance. Persistent abdominal pain, blood in the stool, unexplained weight loss, and lasting changes in bowel habits warrant medical evaluation, particularly in younger adults who may dismiss symptoms as unrelated to cancer.
Author Jessica Williams: "The data from Switzerland should shake every health system into action, because this isn't some anomaly confined to one country, it's a signal that something fundamental is changing in how we get cancer at a younger age."
Comments